跳至主要内容
临床试验/TCTR20221031001
TCTR20221031001已完成不适用

Prevalence and clinicopathological characteristics of programmed death-ligand 1 expression in Thai patients with gastric cancer

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 268 人开始时间: 2022年10月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
268

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1.Tissue samples from patients who had newly diagnosed gastric cancer and underwent either biopsy or surgical treatment in the Maharaj Nakorn Chiang Mai hospital from January 1, 2018, to December 31, 2021
  • 2.Age more than 18 years old.
  • 3.Tissue sample was available to assess PD-L1 expression by immunohistochemistry technique.

排除标准

  • 1.No recorded hospital admission or follow-up data in Maharaj Nakorn Chiang Mai hospital electronic medical record.
  • 2.Diagnosed other types of malignancy (Gastrointestinal stromal tumor, Lymphoma, Neuroendocrine tumor, or Metastatic tumor).
  • 3.Have other active malignancies or during chemotherapy or radiation for other malignancies.

研究者

相似试验